Reprieve Cardiovascular
Milford, Massachusetts, United States · Healthcare, Health Care
Reprieve Cardiovascular Inc. is a startup focusing on developing an intelligent fluid management system for acute decompensated heart failure. Their technology aims to reduce the high rate of readmissions for heart failure patients by providing personalized diuretic dosing and fluid replacement.
Key facts
- Headquarters
- Milford, Massachusetts, United States
- Employees
- 25
- Industries
- Healthcare, Health Care
- Status
- Private
- Website
- reprievecardio.com
- Company page
Recent activity at Reprieve Cardiovascular
- : Reprieve Cardiovascular
- : Reprieve Cardiovascular
- : Reprieve Cardiovascular
- : Heart failure startup emerges with $42 million in financing for its intelligent fluid management system
- : Reprieve Cardiovascular Emerges from Stealth Mode after $42 Million Series A Financing to Bring Intelligent Fluid Management to Heart Failure Patients
- : Reprieve Cardiovascular
- : Reprieve Cardiovascular, Inc.
Reprieve Cardiovascular funding history
| Date | Round | Amount |
|---|---|---|
| Jun 2025 | Venture | $30.9M |
| Oct 2024 | Venture | $5.0M |
| Feb 2024 | Series A | $42.0M |
| Feb 2024 | Series A | $42.0M |
| Nov 2023 | Venture | $12.1M |
Leadership
- Tony Fields, Director
- Hanson III, Director
- James Eadie, Director
- Ethan Benovitz, Director
- Andrew ElBardissi, Director
- Jim Dillon, Executive Officer, Director
- Adam Bartnik, Chief Financial Officer
- Mark Pacyna, Executive Officer
- Gregory Mann, Executive Officer
Verified email and direct lines for Reprieve Cardiovascular’s decision-makers are on Fundz. See plans — or book a 15-minute walkthrough.
Employee benefit plans
Reprieve Cardiovascular files 1 employee benefit plan with the U.S. Department of Labor, including a retirement plan. The next plan year renews in Dec 2026.
Reprieve Cardiovascular in the news
Companies similar to Reprieve Cardiovascular
- Resonant Link · Healthcare, Health Care
- Avenda Health, Inc. · Healthcare, Health Care
- SentiAR · Healthcare, Health Care
- Tempest Therapeutics · Healthcare, Health Care
- Acuitive Technologies · Healthcare, Health Care
About Reprieve Cardiovascular: questions and answers
What does Reprieve Cardiovascular do?
Reprieve Cardiovascular Inc. is a startup focusing on developing an intelligent fluid management system for acute decompensated heart failure. Their technology aims to reduce the high rate of readmissions for heart failure patients by providing personalized diuretic dosing and fluid replacement.
Where is Reprieve Cardiovascular headquartered?
Reprieve Cardiovascular is headquartered in Milford, Massachusetts, United States.
How many employees does Reprieve Cardiovascular have?
Reprieve Cardiovascular has about 25 employees.
Has Reprieve Cardiovascular raised funding?
Yes. Fundz has recorded 5 funding events for Reprieve Cardiovascular. The most recent, $30.9M, was in Jun 2025.
What is the latest news on Reprieve Cardiovascular?
On Jun 05, 2025, Reprieve Cardiovascular
Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy